Researchers have identified a gene called Presenilin1, or PSEN1, as a potential new biomarker for Alzheimer’s disease. In mice and human samples, the researchers…
When Jamie Tyrone opened the e-mail from a direct-to-consumer DNA company, she thought she was satisfying a casual curiosity. Instead, she learned she carries…
Award-winning journalist Jennie Erin Smith spent seven years in mountaintop communities and laboratories in Colombia researching her nonfiction book, Valley of Forgetting. It follows…
Robin McIntyre learned at age 29 that she carries the gene for early-onset Alzheimer’s disease. For this hair stylist based in Las Vegas, the…
Join us Friday, June 13th, at 11 a.m. PT/2 p.m. ET for a Live Talk with award-winning journalist Jennie Erin Smith. Smith will share…
Join us Friday, June 6th, at 11 a.m. PT/2 p.m. ET for a Live Talk with dementia advocate Robin McIntyre Johnson. In the talk,…
At first, scientists had no idea what might cause Alzheimer’s disease and had no underlying protein or pathway to target with treatments. Then came…
There’s a hereditary typo in Doug Whitney’s genetic code: a variant that all but guarantees its carriers will contract Alzheimer’s disease within their lifetime….
From clinical trials to funding cuts: Here’s how changes at NIH are reshaping Alzheimer’s and dementia research. As of September 2024, 495 clinical trials…
There currently no cure or treatment that can completely halt or reverse Alzheimer’s pathology in the brain. One of the biggest obstacles: Even after…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. An Alzheimer’s diagnosis is often talked about…
Alzheimer’s disease affects one in 10 people over the age of 65 and one in three over the age of 85, and its global…
Alzheimer’s disease is often thought of as a condition that only affects the elderly. But around 3.9 million people worldwide aged 30 to 64…
This article was made possible through sponsorship by Alzheon. Being Patient’s editorial team produced the interview with no review/approval process by the sponsor. Alzheimer’s…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. Michele Castro’s mother and brother both passed…